HEPATOLOGY Concise Review early disease recurrence were common events. However, Treatment of Hepatocellular with newer imaging techniques (spiral computed tomogra- phy, magnetic resonance), the additional tumor nests are
Microwave surgery in the treatment of hepatocellular carcinoma
โ Scribed by Prof. Xin-Da Zhou; Zhao-You Tang; Ye-Qin Yu; Zeng-Chen Ma; Dong-Bo Xu; Ya-Xin Zheng; Bo-Henc Zhang
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 472 KB
- Volume
- 9
- Category
- Article
- ISSN
- 8756-0437
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Microwave surgery was employed for the treatment of 50 patients with hepatocellular carcinoma (HCC) and liver cirrhosis, including hepatectomy in 46 patients and in situ coagulation of tumor in 4 patients. In the study, 2,450 MHz microwaves were generated and transmitted to a monopolar needle electrode. For hepatectomy, the needle electrode was inserted into the liver parenchyma to coagulate the liver tissue and this was repeated at 1 cm intervals along the line where incision is anticipated. For unresectable HCC, the needle electrode was directly inserted into HCC to coagulate the cancer in situ. The average amounts of blood loss and blood transfusion for 46 hepatectomies using microwave were 215 ยฑ 189 ml and 274 ยฑ 261ml, respectively. Eighteen patients (39.1%) did not need blood transfusion. A significant lower volume of blood loss and blood transfusion was observed in comparison with 46 matched conventional hepatectomies, 652 ยฑ 1,008 ml and 841 ยฑ 878 mi, respectively, all being P < 0.01. There were no operative mortality and complications, such as delayed bleeding, bile leakage, and abdominal infection. These results indicate that microwave surgery can be utilized safely and effectively in the field of liver surgery.
๐ SIMILAR VOLUMES
In the 1950s, hepatic lobectomy for huge hepatocellular carcinoma (HCC) has benefited 5-10% of HCC patients; in the 1970s, limited resection for small HCC and reresection for recurrence have benefited another 5-10% HCC patients. Cytoreduction and sequential resection for unresectable HCC might be of